Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Recent & Breaking News (NDAQ:IMNN)

Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion

PR Newswire May 31, 2013

Free Research Reports on CLSN, GOV, RVLT and TFM Issued by the Bedford Report

Marketwired May 30, 2013

Celsion Announces ThermoDox® HEAT Study Findings to be presented at the 2013 European Conference on Interventional Oncology (ECIO) in Budapest, Hungary on June 19 and 20, 2013

PR Newswire May 30, 2013

Before the Crowd, How We Found QCOM, SCHW, CLSN and NRG

Marketwired May 29, 2013

Celsion Announces Issuance of Additional Patents Covering ThermoDox® Technologies

PR Newswire May 22, 2013

Celsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)

PR Newswire May 17, 2013

Today's Research on HSP, ALKS, CLSN, THRX, and CHTP

Accesswire May 13, 2013

Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update

PR Newswire May 9, 2013

Celsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013

PR Newswire May 1, 2013

Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013

PR Newswire May 1, 2013

Celsion Corporation Provides Business Update

PR Newswire April 23, 2013

Today's Research on Celsion, Zogenix, Actavis, and Avanir Pharma

PR Newswire April 10, 2013

Free Research Reports on CLSN, CREE, HALO and TSO Issued by the Bedford Report

Marketwired April 8, 2013

Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update

PR Newswire March 18, 2013

Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013

PR Newswire March 12, 2013

Pre-Market Analysis on Celsion, Velti, Heckmann, FuelCell Energy, and Diamond Foods

PR Newswire March 12, 2013

Celsion Corporation Announces $15 Million Registered Direct Offering

PR Newswire February 22, 2013

Free Research Report on NII Holdings, Inc., Denbury Resources Inc., Celsion Corp., ONEOK, Inc. and Ryland Group, Inc. (The)

Marketwired February 13, 2013

Free Research Reports on ONCY, CLSN, ETRM and MOH Issued by the Bedford Report

Marketwired February 11, 2013

Celsion Corporation Provides an Update Regarding ThermoDox® Agreements with Zhejiang HISUN Pharmaceutical Company for China

PR Newswire February 5, 2013